Search Results - Eric F Morand

Refine Results
  1. 1

    Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes by Annaleise V. Sampey, Paul Hutchinson, Eric F. Morand

    Published in Mediators of Inflammation (2000-01-01)
    Get full text
    Article


  2. 2

    Regulation of Annexin I in Rheumatoid Synovial Cells by Glucocorticoids and Interleukin-1 by Eric F. Morand, Pam Hall, Paul Hutchinson, Yuan H. Yang

    Published in Mediators of Inflammation (2006-01-01)
    Get full text
    Article


  3. 3

    1401 Effects of anifrolumab on renal disease in patients with systemic lupus erythematosus by Raj Tummala, Richard A Furie, Eric F Morand, Gabriel Abreu, Catharina Lindholm

    Published in Lupus Science and Medicine (2021-11-01)
    Article


  4. 4

    P54 Screening for primary aldosteronism in hypertensive patients with systemic lupus erythematosus: are we doing it enough? by Fabien B Vincent, Alberta Y Hoi, Eric F Morand, Jun Yang, Matthew Wong, Joanna R Kent

    Published in Lupus Science and Medicine (2024-03-01)
    Article


  5. 5

    Clinical associations of cognitive dysfunction in systemic lupus erythematosus by Rangi Kandane-Rathnayake, Eric F Morand, Vera Golder, Alberta Hoi, Sudha Raghunath, Julie C Stout, Yifat Glikmann-Johnston

    Published in Lupus Science and Medicine (2023-02-01)
    Get full text
    Article


  6. 6

    Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus by Fabien B Vincent, Alberta Y Hoi, Fabienne Mackay, James Harris, Rangi Kandane-Rathnayake, Eric F Morand, Rachel Koelmeyer

    Published in Lupus Science and Medicine (2020-10-01)
    Get full text
    Article


  7. 7

    1502 Lupus low disease activity state attainment in the phase 3 placebo-controlled TULIP long-term extension trial of anifrolumab by Richard A Furie, Eric F Morand, Sule Yavuz, Kenneth C Kalunian, Gabriel Abreu, Ronald van Vollenhoven, Catharina Lindholm, Hussein Al-Mossawi

    Published in Lupus Science and Medicine (2024-05-01)
    Article


  8. 8

    Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus by Hieu T. Nim, Hieu T. Nim, Kathryn Connelly, Fabien B. Vincent, François Petitjean, Alberta Hoi, Rachel Koelmeyer, Sarah E. Boyd, Eric F. Morand

    Published in Frontiers in Immunology (2019-07-01)
    Get full text
    Article


  9. 9

    Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatment by Zhi Feng Sherman Lim, Alberta Y. Hoi, Fabien B. Vincent, Joshua D. Ooi, Eric F. Morand, Maureen Rischmueller, Yi Tian Ting

    Published in Journal of Translational Autoimmunity (2025-12-01)
    Get full text
    Article


  10. 10

    Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus by Melissa Northcott, Linden J. Gearing, Linden J. Gearing, Julie Bonin, Rachel Koelmeyer, Alberta Hoi, Paul J. Hertzog, Paul J. Hertzog, Eric F. Morand

    Published in Frontiers in Immunology (2022-08-01)
    Get full text
    Article


  11. 11

    Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus by Rachel Mende, Fabien B. Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, Emily Lin, Janet Chang, Alberta Y. Hoi, Eric F. Morand, James Harris, Tali Lang

    Published in Frontiers in Immunology (2018-06-01)
    Get full text
    Article


  12. 12

    Correction: Targeting DORIS Remission and LLDAS in SLE: A Review by Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino

    Published in Rheumatology and Therapy (2024-06-01)
    Get full text
    Article


  13. 13

    Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies by Matthew Studham, Cristina Vazquez‐Mateo, Eileen Samy, Philipp Haselmayer, Aida Aydemir, P. Alexander Rolfe, Joan T. Merrill, Eric F. Morand, Julie DeMartino, Amy Kao, Robert Townsend

    Published in ACR Open Rheumatology (2023-10-01)
    Get full text
    Article


  14. 14

    Targeting DORIS Remission and LLDAS in SLE: A Review by Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino

    Published in Rheumatology and Therapy (2023-10-01)
    Get full text
    Article


  15. 15

    LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) by Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson

    Published in Lupus Science and Medicine (2023-07-01)
    Article


  16. 16

    LP-184 Rationale and design of two phase 3, Randomized, double-blind, placebo-controlled studies of the efficacy and safety of litifilimab in adults with active systemic lupus eryt... by Richard A Furie, Kenneth Kalunian, Maria Dall’Era, Eric F Morand, Puja Joshi, Ting Wang, Xing Wei, Catherine Barbey, Ronald FVan Vollenhoven, Stacey Goode-sellers, George Kong, Youmna Lahoud

    Published in Lupus Science and Medicine (2023-07-01)
    Article


  17. 17

    Glucocorticoid-induced leucine zipper (GILZ) regulates testicular FOXO1 activity and spermatogonial stem cell (SSC) function. by Devi Ngo, Qiang Cheng, Anne E O'Connor, Kathleen D DeBoer, Camden Y Lo, Elaine Beaulieu, Mia De Seram, Robin M Hobbs, Moira K O'Bryan, Eric F Morand

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  18. 18

    Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort... by Raj Tummala, Richard A Furie, Laurent Arnaud, Eric F Morand, Martin Aringer, Stephanie Chen, Barnabas Desta, Alberta Hoi, Bo Ding, Christine Peschken, Jonatan Hedberg, Tina Grünfeld Eén, Alessandro Sorrentino, Danuta Kielar

    Published in Lupus Science and Medicine (2025-01-01)
    Get full text
    Article


  19. 19

    Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature by Richard Furie, Raj Tummala, Laurent Arnaud, Eric F Morand, Martin Aringer, Barnabas Desta, Bo Ding, Christine Peschken, Jacob Knagenhjelm, Heide A Stirnadel-Farrant, Eleni Rapsomaniki, Jonatan Hedberg, Caroline Seo, Tina Grünfeld Eén, Alessandro Sorrentino

    Published in Lupus Science and Medicine (2023-08-01)
    Get full text
    Article


  20. 20

    Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ) by Wendy Dankers, Melissa Northcott, Taylah Bennett, Akshay D’Cruz, Rochelle Sherlock, Linden J. Gearing, Paul Hertzog, Brendan Russ, Iolanda Miceli, Sebastian Scheer, Maki Fujishiro, Kunihiro Hayakawa, Keigo Ikeda, Keigo Ikeda, Eric F. Morand, Sarah A. Jones

    Published in Frontiers in Immunology (2022-11-01)
    Get full text
    Article


Search Tools: